In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Shortages Protocol Comes Into Effect

Executive Summary

Serious shortage protocols have come into effect in the UK from the start of July, allowing pharmacists to dispense alternative treatments – including generic versions and even different active substances – when a medicine in shortage has been prescribed.

You may also be interested in...

First UK Serious Shortage Protocol Issued For Fluoxetine

The first Serious Shortage Protocol has been issued by the DHSC to tackle supply disruptions for fluoxetine capsules. The protocol came into effect on 3 October 2019 and will expire at the end of the month.

Stockpiling May Not Solve Brexit Shortages

Industry stockpiling will not cover potential medicine supply shortages for six months if the UK leaves the European Union on 31 October with no deal, the UK’s government has admitted in its ‘reasonable worst-case planning assumptions’.

UK Government Plans Express Freight For Medicines

Express freight services are set to be available to UK medicines firms in the event of no-deal exit from the EU. In return, the UK government wants product-level details of stock levels and supply routes as of the prospective Brexit date of 31 October.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts